Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, AltaThera Pharmaceuticals is raising $4,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Jodi Devlin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AltaThera Pharmaceuticals

AltaThera is a specialty biopharmaceutical company focused on improving the lives of patients by developing and commercializing medicines that address unmet medical needs. We are a mission-driven team serving pediatric patients and those with needs for which few effective treatments are available. We actively collaborate with key opinion-leading physicians to identify these medical needs and develop new treatments to address them. We seek partnerships than can accelerate our efforts to provide therapies that enhance patients’ quality of life.

To learn more about AltaThera Pharmaceuticals, visit http://www.altathera.com/

Contact:
Jodi Devlin, Chief Executive Officer
312-445-8900
jdevlin@altathera.com
https://www.linkedin.com/in/jodidevlin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved